How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Recursion Pharmaceuticals Inc insiders reported 3 transactions totaling $430,930.56. Activity included 2 tax payments ($333,430.56) and 1 sale ($97,500.00) in August 2026. View more Major Holders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results